Timasheva, Y,
Nasibullin, TR,
Tuktarova, IA,
Erdman, VV,
Galiullin, TR,
Zaplakhova, OV,
Bakhtiiarova, KZ (2022) tested using logistic regression analysis under additive genetic model adjusted for sex. Meta
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to
test the therapeutic effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used
lncRNAs
tested as potential therapeutic and diagnostic molecules in cells and animal model experiments
Kudoyarov, E.R.,
Karimov, D.O.,
Bakirov, A.B.,
Mukhammadieva, G.F.,
Karimova, L.K.,
Galimova, R.R. (2022) obtained by
tests that included indicator enzyme identification, and DNA damage. Following the study
Musin, I. I.,
Yashchuk, A.G.,
Pavlov, V.N.,
Wang, J.,
Sun, X.,
Naftulovich, R.A.,
Popova, E.M. (2022) using Miyazaki's technique. Conclusions: Considering the Food and
Drug Administration's 2019 decision
Dzhaubermezov, M.,
Ekomasova, N.,
Mustafin, R.,
Gabidullina, L.,
Galimova, Y.,
Nurgalieva, A.,
Valova, Y.,
Prokofyeva, D.,
Khusnutdinova, E. (2022) hormones, and
drugs, including those used in COVID-19 treatment. Cytochrome
p450 genes are linked